A small Phase 2/3 trial in treatment-resistant depression with completed enrollment but no posted results; the registry record alone cannot support any claim about efficacy or safety.
Reported
Planned enrollment32
Primary outcome measureHamilton Depression Rating Scale
Primary assessment timepointapproximately 17 days after randomization